El-Degheidi is now finding himself forced to provide his clients with alternatives for necessary medicines amid what many say is an acute shortage of major drugs in the Egyptian market.
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
Commvault's executives shared insights on Egypt's unique market potential and the importance of cyber resilience in today's digital economy in an interview with Ahram Online (AO), which took place ...